About Patched domain-containing protein 3
Patched domain-containing protein 3 (PTCHD3) is a protein
from Homo sapiens identified by UniProt accession
Q3KNS1, 954 residues long.
MolForge cross-references it against 0 known binders and
0 disease associations.
Target properties
| Protein name | Patched domain-containing protein 3 |
|---|
| UniProt accession | Q3KNS1 |
|---|
| Gene | PTCHD3 |
|---|
| Organism | Homo sapiens |
|---|
| Length | 954 residues |
|---|
| Molecular weight | — |
|---|
| EC numbers | — |
|---|
| Target class | UNCLASSIFIED |
|---|
| Subcellular location | — |
|---|
| Keywords | — |
|---|
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
|---|
| AF-Q3KNS1-F1 | alphafold | PREDICTED | 81.55 | — |
Amino-acid sequence (954 residues)
MPWVEPKPRP GPEQKPKLTK PDSATGPQWY QESQESESEG KQPPPGPLAP PKSPEPSGPL ASEQDAPLPE GDDAPPRPSM LDDAPRLPLE LDDAPLPEEE TPEPTAICRH RHRCHTDCLE GLLSRTFQWL GWQVGAHPWI FLLAPLMLTA ALGTGFLYLP KDEEEDLEEH YTPVGSPAKA ERRFVQGHFT TNDSYRFSAS RRSTEANFVS LLVVSYSDSL LDPATFAEVS KLDGAVQDLR VAREKGSQIQ YQQVCARYRA LCVPPNPILY AWQVNKTLNL SSISFPAYNH GRHPLYLTGF FGGYILGGSL GMGQLLLRAK AMRLLYYLKT EDPEYDVQSK QWLTHLLDQF TNIKNILALK KIEVVHFTSL SRQLEFEATS VTVIPVFHLA YILIILFAVT SCFRFDCIRN KMCVAAFGVI SAFLAVVSGF GLLLHIGVPF VIIVANSPFL ILGVGVDDMF IMISAWHKTN LADDIRERMS NVYSKAAVSI TITTITNILA LYTGIMSSFR SVQCFCIYTG MTLLFCYFYN ITCFGAFMAL DGKREVVCLC WLKKADPKWP SFKKFCCFPF GSVPDEHGTD IHPISLFFRD YFGPFLTRSE SKYFVVFIYV LYIISSIYGC FHVQEGLDLR NLASDDSYIT PYFNVEENYF SDYGPRVMVI VTKKVDYWDK DVRQKLENCT KIFEKNVYVD KNLTEFWLDA YVQYLKGNSQ DPNEKNTFMN NIPDFLSNFP NFQHDINISS SNEIISSRGF IQTTDVSSSA KKKILLFQLR RIAEDCQIPL MVYNQAFIYF DQYAAILEDT VRNVLVASAA MFIVSLLLIP YPLCSLWVTF AIGSVIVGVT GFMAFWKVNL DSISMINLVI CIGFSFDFSV HISYAFVSSS QPSVNQKSVE ALYLLGYPVL QSAISTIIGV CVLAAAKAYI FRTFFKIMFL VMIFGAAHGL IFIPVFLTFF GRFI
Explore Patched domain-containing protein 3 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets